A Randomized, Double-Blind, Placebo-Controlled Phase 4 S

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled Phase 4 Study to Evaluate the Efficacy and Safety of Entyvio (Vedolizumab IV) in the Treatment of Chronic Pouchitis (EARNEST)
StatusActive
Effective start/end date11/24/156/30/21

Funding

  • TAKEDA DEVELOPMENT CENTER AMERICAS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.